ACTRN12623000118606
Active, not recruiting
未知
Circadian Intervention in the Treatment of Insomnia, Fatigue and Depression of Long-COVID
The Bronowski Institute of Behavioural Neuroscience0 sites3 target enrollmentFebruary 3, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ong Covid
- Sponsor
- The Bronowski Institute of Behavioural Neuroscience
- Enrollment
- 3
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Any patient diagnosed with Long\-COVID by a qualified medical practitioner is eligible. Being an early exploratory trial, we are examining the generalizability of any therapeutic effect to the general diagnosis of the condition of Long\-COVID.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
Clinical study on the treatment of Insomnia by integrating acupuncture and moxibustion based on traditional Chinese medicine theoryinsomniaITMCTR2200005752The Hospital of Chengdu University of TCM
Completed
Phase 4
Investigation of effective treatment of nocturnal hypertension in diabetesocturnal hypertension in type 2 DMJPRN-UMIN000001802Kobe University Graduate School of Medicine Division of deabetes, metabolism and endocrinology50
Completed
Not Applicable
ight treatment for sleep and circadian disruption in kidney donor patientssleep disruption following surgeryNeurological - Studies of the normal brain and nervous systemACTRN12614000494639niversity of Auckland40
Completed
Not Applicable
Treating Comorbid Insomnia with Obstructive sleep Apnoea (COMISA) Study: A new treatment strategy for patients with combined insomnia and sleep apnoea.ACTRN12613001178730Prof Doug McEvoy140
Completed
Not Applicable
The RESET trial: can a novel intervention rapidly re-adjust the body clock to treat jet-lag in healthy volunteers and improve their sleep at high altitude?ISRCTN76074900niversity of Edinburgh35